This project is an application for the continuation of a cooperative agreement (U54), “Mechanisms of Alcoholic Pathology” (MAP), between faculties of the Biomedical/Biotechnology Research Institute
Asialo-rhuEPO, a non-hematopoietic recombinant human erythropoietin (EPO) derivative lacking sialic acid, has been reported to display broad tissue-protective effects against damage triggered by is
It is increasingly clear that proteins of the extracellular matrix (ECM) are key regulators of cell patterning and morphogenesis in the developing nervous system.